FDG PET/CT of primary bone tumors

Area of Science:

• Oncology
• Nuclear Medicine
• Radiology

Background:

• Many primary bone tumors exhibit high Fluorodeoxyglucose (FDG) uptake on Positron Emission Tomography/Computed Tomography (PET/CT) scans.
• FDG avidity alone is insufficient to determine the malignant potential of bone tumors.
• Radiographs and CT imaging are crucial for evaluating the morphologic characteristics of bone lesions.

Purpose of the Study:

• To educate readers on the application of FDG PET/CT in evaluating primary bone tumors.
• To differentiate between malignant and benign primary bone tumors using FDG PET/CT.
• To highlight the role of FDG PET/CT in staging and prognosis of bone malignancies.

Main Methods:

• Review of FDG PET/CT imaging in patients with primary bone tumors.
• Correlation of FDG uptake with tumor histology and grade.
• Analysis of morphologic features on the CT component of PET/CT scans.

Main Results:

• FDG uptake intensity does not reliably predict malignancy in primary bone tumors.
• Morphologic assessment on CT is essential for accurate lesion characterization.
• FDG PET/CT is useful for staging and can reflect prognosis in certain bone malignancies.

Conclusions:

• Characterizing primary bone tumors requires integrating FDG uptake with CT morphologic evaluation.
• FDG avidity and morphologic features aid in staging and assessing treatment response.
• FDG PET/CT offers valuable insights into the management of osteosarcoma and Ewing sarcoma.